{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T23:28:26Z","timestamp":1782602906170,"version":"3.54.5"},"reference-count":17,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1097\/pas.0000000000000571","type":"journal-article","created":{"date-parts":[[2015,11,17]],"date-time":"2015-11-17T12:52:48Z","timestamp":1447764768000},"page":"378-385","source":"Crossref","is-referenced-by-count":42,"title":["CD30 Expression by B and T Cells"],"prefix":"10.1097","volume":"40","author":[{"given":"Arantza","family":"Onaindia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nerea","family":"Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santiago","family":"Montes-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Socorro M.","family":"Rodr\u00edguez-Pinilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cereceda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose B.","family":"Revert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar","family":"Ortega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoni","family":"Tardio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc\u00eda","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia","family":"Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francisca I.","family":"Camacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Gonz\u00e1lez-Vela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel A.","family":"Piris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R2-11-20210131","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.1200\/JCO.2012.44.7524","article-title":". Survival of patients with peripheral T-cell lymphoma after first relapse or progression: spectrum of disease and rare long-term survivors.","volume":"31","author":"Mak","year":"2013","journal-title":"J Clin Oncol"},{"key":"R3-11-20210131","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1200\/JCO.2010.29.9024","article-title":". Pralatrexate in patients with relapsed or refractory peripheral T-cell lymphoma: results from the pivotal PROPEL study.","volume":"29","author":"OConnor","year":"2011","journal-title":"J Clin Oncol"},{"key":"R4-11-20210131","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1200\/JCO.2011.37.4223","article-title":". Results from a pivotal, open-label, phase II study of romidepsin in relapsed or refractory peripheral T-cell lymphoma after prior systemic therapy.","volume":"30","author":"Coiffier","year":"2012","journal-title":"J Clin Oncol"},{"key":"R5-11-20210131","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1200\/JCO.2011.38.0402","article-title":". Brentuximab vedotin (SGN-35) in patients with relapsed or refractory systemic anaplastic large-cell lymphoma: results of a phase II study.","volume":"30","author":"Pro","year":"2012","journal-title":"J Clin Oncol"},{"key":"R6-11-20210131","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/0092-8674(92)90180-K","article-title":". Molecular cloning and expression of a new member of the nerve growth factor receptor family that is characteristic for Hodgkins disease.","volume":"68","author":"Durkop","year":"1992","journal-title":"Cell"},{"key":"R7-11-20210131","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.1182\/blood-2003-01-0039","article-title":". cAC10-vcMMAE, an anti-CD30-monomethyl auristatin E conjugate with potent and selective antitumor activity.","volume":"102","author":"Francisco","year":"2003","journal-title":"Blood"},{"key":"R8-11-20210131","doi-asserted-by":"crossref","first-page":"3095","DOI":"10.1182\/blood-2013-12-542142","article-title":". Objective responses in relapsed T-cell lymphomas with single-agent brentuximab vedotin.","volume":"123","author":"Horwitz","year":"2014","journal-title":"Blood"},{"key":"R9-11-20210131","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1158\/1078-0432.CCR-12-3151","article-title":". NIK controls classical and alternative NF-B activation and is necessary for the survival of human T-cell lymphoma cells.","volume":"19","author":"Odqvist","year":"2013","journal-title":"Clin Cancer Res"},{"key":"R10-11-20210131","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/annonc\/mdq359","article-title":". Comparison of four prognostic scores in peripheral T-cell lymphoma.","volume":"22","author":"Gutierrez-Garcia","year":"2011","journal-title":"Ann Oncol"},{"key":"R11-11-20210131","doi-asserted-by":"crossref","first-page":"2474","DOI":"10.1182\/blood-2003-09-3080","article-title":". Peripheral T-cell lymphoma unspecified (PTCL-U): a new prognostic model from a retrospective multicentric clinical study.","volume":"103","author":"Gallamini","year":"2004","journal-title":"Blood"},{"key":"R12-11-20210131","doi-asserted-by":"crossref","first-page":"2472","DOI":"10.1200\/JCO.2005.03.6327","article-title":". Marker expression in peripheral T-cell lymphoma: a proposed clinical-pathologic prognostic score.","volume":"24","author":"Went","year":"2006","journal-title":"J Clin Oncol"},{"key":"R13-11-20210131","doi-asserted-by":"crossref","first-page":"3402","DOI":"10.1182\/blood-2010-09-310342","article-title":". Peripheral T-cell lymphoma, not otherwise specified: a report of 340 cases from the International Peripheral T-cell Lymphoma Project.","volume":"117","author":"Weisenburger","year":"2011","journal-title":"Blood"},{"key":"R14-11-20210131","doi-asserted-by":"crossref","first-page":"2983","DOI":"10.1182\/blood-2014-07-584953","article-title":". Immunohistochemistry as a valuable tool to assess CD30 expression in peripheral T-cell lymphomas: high correlation with mRNA levels.","volume":"124","author":"Bossard","year":"2014","journal-title":"Blood"},{"key":"R15-11-20210131","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S1074-7613(00)00004-2","article-title":". Wnt signaling regulates B lymphocyte proliferation through a LEF-1 dependent mechanism.","volume":"13","author":"Reya","year":"2000","journal-title":"Immunity"},{"key":"R16-11-20210131","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1440-1827.2007.02195.x","article-title":". Usefulness of flow cytometry for differential diagnosis of precursor and peripheral T-cell and NK-cell lymphomas: analysis of 490 cases.","volume":"58","author":"Karube","year":"2008","journal-title":"Pathol Int"},{"key":"R19-11-20210131","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.3324\/haematol.2013.084913","article-title":". CD30 expression in peripheral T-cell lymphomas.","volume":"98","author":"Sabattini","year":"2013","journal-title":"Haematologica"},{"key":"R20-11-20210131","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/2040620712443076","article-title":"Safety and efficacy of brentuximab vedotin in patients with Hodgkin lymphoma or systemic anaplastic large cell lymphoma.","volume":"3","author":"Vaklavas","year":"2012","journal-title":"Ther Adv Hematol"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000000571","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T04:46:08Z","timestamp":1620967568000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000478-201603000-00011"}},"subtitle":["A Frequent Finding in Angioimmunoblastic T-Cell Lymphoma and Peripheral T-Cell Lymphoma-Not Otherwise Specified"],"short-title":[],"issued":{"date-parts":[[2016,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000000571","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2016,3]]}}}